addressalign-toparrow-leftarrow-rightbackbellblockcalendarcameraccwcheckchevron-downchevron-leftchevron-rightchevron-small-downchevron-small-leftchevron-small-rightchevron-small-upchevron-upcircle-with-checkcircle-with-crosscircle-with-pluscontroller-playcrossdots-three-verticaleditemptyheartexporteye-with-lineeyefacebookfolderfullheartglobegmailgooglegroupshelp-with-circleimageimagesinstagramFill 1light-bulblinklocation-pinm-swarmSearchmailmessagesminusmoremuplabelShape 3 + Rectangle 1ShapeoutlookpersonJoin Group on CardStartprice-ribbonprintShapeShapeShapeShapeImported LayersImported LayersImported Layersshieldstartickettrashtriangle-downtriangle-uptwitteruserwarningyahoo

What is the Value of Your IP? Patent Strategies & Commercialization

  • May 30, 2013 · 5:45 PM
  • This location is shown only to members

What is the Value of Your IP?

Patent Strategies and Commercializing Your IP Assets

Thursday, May 30, 2013

Intellectual Property (IP) is the embodiment of biomed innovation which makes it credible to investors and businesspeople, while setting up fences against commercial plagiarism by third parties.  IP is often seen as the "crown jewels" of a biomed company and, as such, it needs to be protected and exploited in a well thought-out manner.

IP is often far from the pure science and therefore can be overlooked by scientific investigators.  However in order to increase the chance for the successful future commercial exploitation of technology assets, it is essential to ensure that there is a solid foundation to the underlying IP – something that should ideally be dealt with at the early stage of the biomed venture.  Practice has shown that many scientific investigators have lost their chance of commercializing their discovery by publicly disclosing it without the appropriate protective measures in place.

The panel which JBNF-Biomed is presenting at this event will discuss practical issues that scientists and entrepreneurs in the biomed field should consider in order to protect their innovations and increase the chances for successfully commercializing their IP.  Discussion will also focus on IP strategies for biomed startups, the role of the technology transfer companies at universities and hospitals, and key issues to consider when negotiating IP commercialization arrangements. The panel consists of two leading patent attorneys, a leading commercial IP lawyer and an experienced businessperson from the pharmaceutical industry.

 

Program:

18:00 Opening
Moderator: Daniel Green - Partner, Yigal Arnon & Co. Law Firm

Greetings - Prof Israel Ringel, Head of Life Science - Azrieli College of Engineering

Chen Levin, Bio-Jerusalem

Dr Yakov Nachmias, Hebrew University

"Accelerating Jerusalem Biomed Innovation"

18:10
Panel discussion on "What is the Value of Your IP?

Patent Strategies and Commercializing Your IP Assets"

Panelists:

Sanford Colb - Founder, Sanford T. Colb & Co., Intellectual Property Law (http://www.stc.co.il/index.asp)
Jeremy Ben David - Founder and CEO, JMB Davis Ben-David - Patents, Trademarks & Designs (http://www.jmb.co.il/index.html)
Josh Blacher - CEO, ViDAC Pharma (http://vidacpharma.com/)
Daniel Green - Partner, Yigal Arnon & Co. Law Firm (http://www.arnon.co.il/)

18:40 Q&A

19:00 Tour of the Pharma Engineering facility

19:30 -21:00 Networking

This event is sponsored by the Azrieli Academic College of Engineering - Jerusalem which is hosting the event and providing the refreshments.

Pharmaceutical Engineering at Azrieli Academic College of Engineering

The college partnered with TEVA Pharmaceutical Industries Ltd. in establishing its Pharmaceutical Engineering Department which opened in 2008. With a cutting-edge curriculum, the B.Sc. program in Pharmaceutical Engineering provides students with the engineering tools required for the development and manufacturing of drugs, raw materials required for drug production, and drug carriers.

Bios of our panelists:

Sanford Colb -CEO, Sanford T. Colb & Co

Sanford T. Colb is the founder of Sanford T. Colb & Co., Intellectual Property Law (http://www.stc.co.il/index.asp) He is licensed to practice before the Israel Patent Office and the US Patent and Trademark Office, and is a licensed attorney in Israel and in the US. Mr. Colb is a member of the American Patent Law Association, International Law Committee, Israel Association of Patent Attorneys, AIPPI, Licensing Executives Society, American Arbitration Association, International Trademark Association, Pharmaceutical Trade Marks Group, and American Bar Association. He has been a lecturer of Intellectual Property Law at Bar Ilan University and Netanya Academic College.Mr. Colb has an M.A. (Honors) from Cambridge University and a B.A. (magna cum laude) and M.Sc. in Physics from the University of Pennsylvania. He was awarded the Silver Medal of the Royal Society of Arts, London, and was a Thouron Scholar at Cambridge University. Mr. Colb also holds a J.D. degree from Harvard Law School.

 

Jeremy Ben David, Founder and CEO, JMB Davis Ben-David - Patents, Trademarks & Designs (http://www.jmb.co.il/index.html)

A licensed Israel Patent and Trademark Attorney since the mid-1980s, Jeremy Ben David holds a B.Sc (Hons) in Civil Engineering from the Polytechnic of the South Bank, London. He moved to Israel in 1984.
Mr. Ben David's specialty includes assisting client companies by formulating Intellectual Property strategies, including registering patents, trademarks and designs in Israel and internationally, including life sciences. Jeremy has successfully drafted and prosecuted a notable portfolio of patent applications in Israel and overseas since the 1980s. Key areas include medical devices, computer-related hardware and software inventions, water technology, aircraft and military related systems, and alternative energy. He has registered designs for clients from around the world for products in a wide variety of industries. In addition, as a regular participant in major INTA and AIPPI events, Mr. Ben David has built a network of foreign associates.


Josh Blacher - CEO, ViDAC Pharma (http://vidacpharma.com/)

Josh Blacher is the founding CEO of ViDAC Pharma, a pre-clinical stage drug discovery and development company focusing on cancer metabolism. In that capacity, Mr. Blacher is responsible for the strategic direction of the company, as well as its day-to-day operations, business development and finance. Previously, he served as Director of Business Development at Teva Innovative Ventures, Teva’s early-stage licensing and investment division. While at Teva, Mr. Blacher executed investment transactions aggregating $2.1B in deal value, which spanned a wide range of therapeutic areas and stages of development. In addition, he helped manage Teva’s investment portfolio of approximately $200 million. Prior to that, he was a founding executive of a VC-funded start-up. He held key positions in investment management at Deutsche Bank and Morgan Stanley, as well as strategic advisory at Lehman Brothers. Mr. Blacher holds an MBA in Finance from Columbia Business School.


Daniel Green, Partner, Yigal Arnon & Co. Law Firm (http://www.arnon.co.il/)

Daniel Green is a partner at Yigal Arnon & Co., one of Israel’s leading, full-service law firms. His practice focuses on the commercialization of technology and intellectual property assets, with a focus on licensing and corporate partnering. Mr. Green has represented emerging and established technology companies in the information technology, e-commerce, clean-tech, biotechnology, medical device and pharmaceutical industries. He has extensive experience in structuring, negotiating and documenting complex licensing, development and technology transfer arrangements, Internet and e-commerce agreements, OEM, VAR and other distribution and supply arrangements, joint ventures and other commercial transactions.
Prior to joining Yigal Arnon & Co., Mr. Green practiced law in Toronto, Canada. He earned his law degree at Osgoode Hall Law School in Toronto, and also holds a B.A.(hon.) in Political Science from McGill University in Montreal and an M.A. (magna cum laude) in Middle East History from Tel Aviv.

-------------------

Click here for Directions on how to find your way to the Azrieli Academic College of Engineering - Jerusalem, 26 Yaakov Shreibom St., Ramat Beit Hakerem, Jerusalem.

 

For questions, you can email us at [masked]

Hope to see you there!!!!

Join or login to comment.

  • Kfir N.

    Was very interesting, it is very important to continue to hold such meetings ..
    I learned a lot and would love to participate in the next meeting :)

    Kfir,

    June 3, 2013

  • Dr Sue Lifshitz, patent a.

    I'm down with a sore throat- sorry!

    May 30, 2013

  • Kenichi H.

    Would you clarify the location of the event? This event page states that the location is Yaakov Shreibom 26, but the google map link provided in the email reminder sent today says Moshe Kol 25. Which is it?

    2 · May 30, 2013

    • Joe van Z.

      Map in Hebrew - מפה בעברית http://www.jce.ac.il/...­

      May 30, 2013

    • Avigail F.

      Google is difficult. Please go to the end of the street.
      This is the map at the College site:
      http://english.jce.ac...­}

      May 30, 2013

  • mordell k.

    The Geophysical Institute of Israel
    P.O.B 182, LOD 71100, ISRAEL
    Phone:[masked] ;[masked]rogram looks good !

    May 13, 2013

  • Eugene B.

    Unfortunately I am arriving too late to join the meeting... hope to meet with many of you the week after while I will be staying in Jerusalem.
    Please let me know who/when is interested to meet and discuss both topics of technology commercialization and areas of technologies scouting for my other clients.

    May 13, 2013

48 went

Our Sponsors

Sign up

Meetup members, Log in

By clicking "Sign up" or "Sign up using Facebook", you confirm that you accept our Terms of Service & Privacy Policy